KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)

AbCellera Biologics (ABCL) has disclosed Debt Ratio for 6 consecutive years, with 0.01 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Debt Ratio fell 81.44% year-over-year to 0.01, compared with a TTM value of 0.01 through Mar 2025, down 81.44%, and an annual FY2024 reading of 0.01, down 82.48% over the prior year.
  • Debt Ratio was 0.01 for Q1 2025 at AbCellera Biologics, up from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q2 2023 and bottomed at 0.01 in Q4 2024.
  • Average Debt Ratio over 5 years is 0.02, with a median of 0.02 recorded in 2021.
  • The sharpest move saw Debt Ratio soared 113.92% in 2022, then tumbled 82.48% in 2024.
  • Year by year, Debt Ratio stood at 0.02 in 2021, then soared by 64.96% to 0.03 in 2022, then increased by 18.22% to 0.03 in 2023, then tumbled by 82.48% to 0.01 in 2024, then increased by 9.78% to 0.01 in 2025.
  • Business Quant data shows Debt Ratio for ABCL at 0.01 in Q1 2025, 0.01 in Q4 2024, and 0.01 in Q3 2024.